{
  "turn_global_index": 414,
  "session_index": 37,
  "session_id": "ultrachat_91693",
  "turn_in_session": 3,
  "date": "2023/03/01 (Wed) 00:25",
  "role": "assistant",
  "content": "Sure, here are some more details about the CRISPR gene editing research conducted at the University of California, Berkeley:\n\nIn 2017, a team of researchers at UC Berkeley led by Dr. Jennifer Doudna and Dr. Shoukhrat Mitalipov used CRISPR gene editing technology to edit DNA in human embryos. CRISPR is a tool that allows researchers to precisely edit DNA sequences, and it has the potential to cure genetic diseases and enhance certain desirable traits.\n\nThe researchers used CRISPR to target a specific genetic mutation responsible for a heart condition called hypertrophic cardiomyopathy. They injected the CRISPR-Cas9 complex into healthy human eggs along with sperm carrying the genetic mutation. The CRISPR-Cas9 complex edited the DNA of the fertilized eggs, and the team was able to show that they had corrected the mutation in some of the embryos.\n\nThis was the first time that CRISPR had been used to edit genes in human embryos, and it was a significant breakthrough in the field of gene editing. However, there were also concerns about the ethics of using CRISPR to edit human embryos, and the researchers emphasized that their research was only intended for laboratory studies and not for clinical applications.\n\nThe study was published in the journal Nature in August 2017, and it generated significant media attention and controversy around the potential applications and implications of gene editing technology.",
  "has_answer": false
}